Unfortunately, this website doesn't work in your browser.
The browser you are using is no longer supported by Microsoft—we highly recommend upgrading as soon as possible.

MCI Health Investment Ltd Acquired HTC Group Ltd

July 2019 Not Disclosed

Back to Deals

growth strategy

Project Castle

July 2019 Not Disclosed

About the client

Headquartered in Watford, the Company is a leading independent provider of bulk health supplements to healthcare, beauty and independent retailers across the UK. Customers include Holland & Barrett, Boots and The Hut Group.

Originally founded in 1983, the business enjoys a strong market position as a trusted partner offering an excellent selection of high-quality vitamins, minerals, sports nutrition and dietary aids. By focusing on consumer needs and health supplement developments, HTC is able to deliver both changing formulations and delivery mechanisms that allow its customers to stay relevant.

About the deal

HTC is forecasting £25 Million turnover with an EBITDA of c.£3M. The management team, led by Peter Groves (MD), will remain in the business beyond the transaction to further drive the growth of the business.

Commenting on the acquisition, David O’Brien, a Director of MCI, said: “HTC offers a high-quality product following decades of research and development of their formulas. We are delighted to have invested into the natural health and well-being a sector which continues to be a strong choice for people of all generations and look to grow the offer across various platforms.”

MCI Health was advised by Neil Mitchell and Rob Bennett at Rickitt Mitchell.

"HTC was a great strategic acquisition for MCI Health, and they are delighted to have invested into the natural health and well-being sector."

Neil Mitchell | Rickitt Mitchell